The Stop TB Partnership is a unique and innovative global health
organization that brings together partners, expertise, funding, commodities,
and people-centered services in our shared mission to end TB by 2030.
Founded in 2001, the Stop TB Partnership is a United Nations (UN) hosted
organization that takes bold and smart risks to serve and amplify the voices of
the people, communities, stakeholders, and partners from countries affected by
TB.
The Stop TB Partnership is guided by three (3) strategic goals to:
- Advocate,
catalyze, and facilitate sustained coordination and collaboration among
partners;
- Support
the development, replication, and scale-up of innovative approaches and
tools; and
- Facilitate
global, equitable access to TB diagnostics and medicines.
The Stop TB Partnership’s comprehensive range of strategic and technical
expertise and our willingness to push boundaries are crucial factors in
reaching the targets agreed upon by Heads of States and the TB
community-at-large to end TB by 2030.
The Stop TB Partnership’s Strategic Initiatives & Innovative
Financing (SIIF) Team leads the conceptualization, design, roll-out, and
implementation of ground-breaking initiatives and projects within the
Secretariat to bring the “Silicon Valley” mindset and innovations to high TB
burden countries and leverage multi-sectoral collaboration, including the
private sector, to address systematic barriers in the TB and global health
space. Thus far, SIIF, along with our key partners, has conceptualized and
designed two new initiatives – (1) Re-Imagining Care and (2) Accelerator for
Impact (a4i), respectively.
As a follow-up to the first ever TB Innovation Summit and UN High-Level
Meeting on TB (UNHLM on TB) in September 2018, the Stop TB Partnership and our
key partners are working to “re-imagine care” in high TB burden countries, now
and in the future, by making it as convenient as possible for country
programmes, service providers, and, most importantly, the people affected by TB
to provide and access care that put people’s circumstances, preferences, and
needs at the forefront of decision-making. This includes:
- Providing
high TB burden countries with a packaged set of solutions in order for healthcare providers to leverage the most up to date
products and technologies to more efficiently and effectively prevent,
diagnose, treat, and cure people and
- Pivoting
to a more digitalized, virtual, and on-demand care model to bring services
to the people across disease areas (i.e., communicable and
non-communicable) within the context of Universal Health Coverage (UHC),
to ensure all people, including the most marginalized, have access to
affordable and quality care.
a4i is a public-sector venture capital fund, which aims to: (1) pivot
the care model to become more digitalized, virtual, and on-demand and (2)
catalyze the rapid roll-out of emerging technologies (i.e., artificial
intelligence/machine learning, blockchain, tele-care/tele-machine, wearables,
etc.), in high TB burden countries, by:
- Identifying
and investing in emerging technologies, from high-income markets and high
TB burden countries, to pivot the care model to become more digitalized,
virtual, and on-demand;
- Supporting
innovators to cross the second “valley of death” (i.e., from
commercialization to roll-out);
- Financing
critical activities to generate demand in early adopter countries;
- Creating
a network of operating teams and key partners to drive efficient product
launches; and
- Achieving
a return on investment to ensure financial sustainability and unlock new
capital from financial markets and market investors.